Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23409164 | 0.81 | EPHX2 (0.47) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL23409161 | 0.78 | CNR1 (0.38) | CNR1 | |
| SCHEMBL15201102 | 0.69 | EPHX2 (0.39) | — | |
| SCHEMBL11858086 | 0.69 | CNR1 (0.53) | CNR1ALDH1A1HPGDDUSP3 | |
| SCHEMBL11858798 | 0.69 | CNR1 (0.53) | CNR1ALDH1A1HPGDDUSP3 | |
| SCHEMBL16386592 | 0.69 | CNR1 (0.53) | CNR1ALDH1A1HPGDDUSP3 | |
| SCHEMBL23391370 | 0.68 | ALDH1A1 (0.46) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL23391367 | 0.68 | ALDH1A1 (0.46) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL23409187 | 0.68 | CNR1 (0.37) | CNR1CNR2ALDH1A1HPGDDUSP3 | |
| SCHEMBL21585282 | 0.68 | EPHX2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210155640-A1 | LINOLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID LINOLEIC ACID DERIVATIVES, AND THEIR USES | EKTAH (FR) | 2021-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210155640-A1 | LINOLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID LINOLEIC ACID DERIVATIVES, AND THEIR USES | ALOX15, ALOX12, ALOX15B | CNR1 582/4885CNR2 680/4885MEN1 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.